Derren Nathan
Head of Equity Research
Derren leads our Equity Research team with more than 15 years of experience in his field. Derren enjoys exploring the complex pharmaceutical sector and presenting share ideas for retail investors. He focuses on identifying exceptional companies poised for long-term success through outstanding customer propositions, translating into potential market-beating growth or sustainable dividends.
Latest content from Derren
December 2025
November 2025
Whitbread (trading update): demand improves, growing cost pressure
28th November 2025
Mitchells & Butlers (FY Results): trading strong into the new year
28th November 2025
Alibaba (Q2 results): revenue growth impresses as profit tanks
25th November 2025
Novo Nordisk (Announcement): Alzheimer’s trial disappoints
24th November 2025
Next week on the stock market
21st November 2025
Imperial Brands (FY Results): no surprises
18th November 2025
CVS (Trading Update): maintains momentum
18th November 2025
Next week on the stock market
14th November 2025
Next week on the stock market
7th November 2025
JDW (Q1 trading update): resilient start
5th November 2025
Novo Nordisk (Q3 results): another downgrade
5th November 2025
Cameco (Q3 results): pricing strong as volumes falter
5th November 2025
BP (Q3 results): production volumes and profits rise
4th November 2025
October 2025
Shell (Q3 results): strong numbers and outlook
30th October 2025
Eli Lilly (Q3 results): strong financial and clinical progress
30th October 2025
Mastercard (Q3 results): small beat, soft guidance
30th October 2025
Visa (Q4 results): no signs of weakness
29th October 2025
GSK (Q3 Results): guidance upgraded
29th October 2025
Cameco (Announcement): US Government backs Westinghouse
28th October 2025
PayPal (Q3 results): improving outlook
28th October 2025
Where are the opportunities to invest in healthcare? – 3 share ideas
17th October 2025
Next week on the stock market
17th October 2025
Croda (Q3 Update): sales beat, outlook unchanged
16th October 2025
Whitbread (HY Results): second half headwinds flagged
16th October 2025
CVS Group (CMA Investigation): provisional decision
15th October 2025
Next week on the stock market
10th October 2025
Imperial Brands (FY Update): trading in line
7th October 2025
CVS Group (FY results): no surprises
7th October 2025
Next week on the stock market
3rd October 2025
J D Wetherspoon (FY results): slowing growth
3rd October 2025
Tesco (H1 results): full-year guidance slightly raised
2nd October 2025
Taylor Wimpey (Trading Update): guidance unchanged
1st October 2025
September 2025
Carnival (Q3 results): small upgrade to full year guidance
29th September 2025
GSK (Announcement): CEO succession confirmed
29th September 2025
Five shares to watch in 2025 – how are they performing?
26th September 2025
Mitchells & Butlers (FY Update): Guidance In-Line
25th September 2025
Alibaba: shares rally on AI initiatives
24th September 2025
CEOs making a difference – three share ideas
17th September 2025
Anglo American: merger agreement with Teck resources
9th September 2025
August 2025
Alibaba: first quarter sales disappoint but cloud growth surges
29th August 2025
Next week on the stock market
15th August 2025
Next week on the stock market
8th August 2025
What do VCTs invest in? – Plus examples of some of the highs and lows
7th August 2025
Eli Lilly: guidance raised after second quarter beat
7th August 2025
Glencore: First half profits fall on lower coal prices
6th August 2025
Novo Nordisk: first half growth tempered by falling market share
6th August 2025
Smith & Nephew: strong first half, guidance unchanged
5th August 2025
BP: beats second quarter forecasts, buyback steady at $750mn
5th August 2025
Mastercard: Q2 beat, guidance nudged upwards
1st August 2025
Next week on the stock market
1st August 2025
Cameco: Q2 beat, Westinghouse outlook raised
1st August 2025
July 2025
British American Tobacco: full-year guidance firms as US starts to recover
31st July 2025
Haleon: full-year revenue guidance cut, profit outlook remains healthy
31st July 2025
Shell: second quarter profit falls but buybacks continue
31st July 2025
Anglo American: tough diamond market drags on first half performance
31st July 2025
GSK: heading for top end of guidance after robust Q2
30th July 2025
Is there a nuclear energy renaissance? – plus 2 share ideas
30th July 2025
Visa: Q3 results beat expectations
30th July 2025
Rio Tinto: lower prices and tariff impact push H1 profits lower
30th July 2025
Baker Hughes: $13.6bn agreement to acquire Chart Industries
30th July 2025
AstraZeneca: guidance unchanged after solid first half growth
29th July 2025
PayPal: solid Q2, guidance nudged higher
29th July 2025
Novo Nordisk: full-year guidance cut, new CEO announced
29th July 2025
Croda: H1 sales and margins improve in challenging environment
29th July 2025
Next week on the stock market
25th July 2025
Mitchells & Butlers: strong Q3 trading performance
25th July 2025
CVS Group: full year trading in-line, underlying sales growth stalls
24th July 2025
JD Wetherspoon: growing steadily in final quarter
23rd July 2025
Baker Hughes: second-quarter revenue dips, but margins improve
23rd July 2025
FTSE 100 hits 9000 and new record high – 3 stocks to watch
22nd July 2025
SSE: weather dents Q1 renewables output
17th July 2025
Diageo: CEO steps down with immediate effect
17th July 2025
easyJet: strong Q3, but French strikers weigh on outlook
17th July 2025
Rio Tinto: Iron Ore boss Trott to become CEO
15th July 2025
Next week on the stock market
4th July 2025
US stock market reaches new record high – 3 S&P 500 share ideas
2nd July 2025
June 2025
Carnival: guidance raised after strong second quarter
24th June 2025
Next week on the stock market
20th June 2025
Whitbread: first quarter sales slip
19th June 2025
5 shares to watch in 2025 – how are they performing so far this year?
6th June 2025
British American Tobacco: revenue guidance ticks up at half year update
3rd June 2025
May 2025
Investing in weight-loss drug stocks – who are the frontrunners?
30th May 2025
Next week on the stock market
30th May 2025
NVIDIA: first quarter demonstrates strong underlying demand
29th May 2025
Pets at Home: full-year profit as expected but guidance lower this year
28th May 2025
Rio Tinto: Jakob Stausholm CEO to step down later this year
22nd May 2025
British Land: robust results but near-term outlook disappoints
22nd May 2025
Tate & Lyle: full year results meet expectations, soft outlook
22nd May 2025
Mitchells & Butlers: strong first half, market remains robust
22nd May 2025
Greggs: sales growth picks up after a slow start to the year
20th May 2025
Novo Nordisk: CEO to step down due to market challenges
19th May 2025
Primary Health Properties: raises bid to £1.68bn to acquire Assura
19th May 2025
Alibaba: Q4 profits grow, but cash flow comes under pressure
15th May 2025
Aviva: robust Q1, Direct Line deal expected to close mid-year
15th May 2025
Experian: More growth expected after topping margin guidance
14th May 2025
Compass Group: full year guidance unchanged after strong first half
14th May 2025
Social handles
@nathan_derren
CV
Head of Equity Research
Hargreaves Lansdown
July 2022 - Present
Head of Research
Hybridian LLP
July 2018 - July 2022 • 4 yrs 1 mo
Investment research
Hybridian LLP
Apr 2014 - July 2022 • 8 yrs 4 mos
In the press
Press articles quoting or featuring our experts and spokespeople. Hargreaves Lansdown is not responsible for these articles’ content and accuracy and may not share the views of the author or publication listed below.
dailymail.co.uk
Chancellor Jeremy Hunt's plan to sell off NatWest shares 'could cost taxpayers £28bn'
morningstar.com
Traders boost bets on mid-2024 rate cut by Bank of England as U.K. jobs market cools
thisismoney.co.uk
Analysts eye more M&A for Britain's hospitality sector